Gilead starts building manufacturing hub under $32 billion planned US investments

Gilead Sciences (GILD.O), opens new tab said on Wednesday it has started work on a new pharmaceutical development and manufacturing hub at its headquarters in Foster City, California, as part of its planned $32 billion investment in domestic manufacturing.

Major U.S. drugmakers such as Eli Lilly (LLY.N), opens new tab, Johnson & Johnson (JNJ.N), opens new tab, Merck (MRK.N), opens new tab and Bristol Myers Squibb (BMY.N), opens new tab have also announced big investments this year to boost domestic production, as tariffs threaten to raise costs and President Donald Trump pushes to bring more manufacturing to America.Businesses are constantly looking for strategies that will improve their bottom line, whether it be investigating potential cryptocurrency investments or looking for ways to streamline their production strategy and supply chain.

Read more.